Uttar Pradesh, India -- (SBWIRE) -- 11/11/2019 -- Vaccines can be defined as a biological preparations aimed at providing active-acquired immunity against particular medical conditions. The typically composition of a vaccine composes of an agent resembling a disease-causing microorganism (in weakened/killed forms). Vaccines are responsible for worldwide eradication of diseases like polio, measles, and tetanus. Diseases like cholera, hepatitis, influenza, and others can be effectively treated through the administration of the vaccine.

In recent years, the global prevalence of diseases like cholera, influenza, and others have increased, boosting the vaccine market. Presence of such factors in the market along with rising healthcare expenditure, government support for vaccination, and growing awareness drives the market growth. In 2016, it is estimated that 85% of the global pediatric population (one year old) were vaccinated against measles.
From the past few years, researches have suggested that AIDS can be treated through vaccination. However, the there is no commercially available vaccine in medicine against the HIV, but the market witnesses huge R&D and clinical trials for the same. Thus, vaccination against AIDS is major opportunity in the global human vaccine market.

Conclusively, the human vaccine market is estimated to grow with an approximate CAGR of 8.6% during the forecast period.

The global human vaccine market has been segmented into indication, type, route of administration, age group, distribution channel, and region. On the basis of indication the market has been segmented into, BCG (DescriptionBacillus Calmette-Guérin) vaccine, DTP1, DTP 3, HepB, HepB3, Hib3, MCV1, MCV2, MCV3, PCV3, Pol3, RCV1, and others. Based on type, the market has been segmented into conjugate, recombinant, inactivated, combination, and attenuated. On the basis of route of administration, the human vaccine market had been segmented into pediatrics, adolescents, adults, and geriatric. Based on distribution channel the market has been segmented into hospital pharmacies and drugstores.

DOWNLOAD FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=IC1655

Regional Overview

By region the market has been segmented into four major geographies the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas was estimated to lead the market in 2018 owing to presence of developed economies and key players within the region. In the survey of 2017, it was reported that 73% of the US population thought vaccination to be effective in avoiding measles, mumps, and rubella.
Europe followed America and stood second in the market. Asia Pacific is the fastest growing in the global human vaccine market owing huge patient pool, developing healthcare expenditure, presence of local players and growing penetration of global market players. Moreover, government support boosts the market. The Middle East & Africa held the least share in the global human vaccine market.

Competitor Landscape

GlaxoSmithKline, Merck, Pfizer, and Sanofi are some of the major players in the global human vaccine market. They rely on collaborations, acquisitions, and product launches to increase their market share. In 2017, Merck & Co. generated USD 6.5 billion through vaccines. Moreover, the market also witnesses local players operating in the market. The research study explains a descriptive competitive landscape, clinical trials data, along with pricing analysis and gap analysis.

Reasons to Purchase this report:
- Get market Intelligence (MI) sheet in Excel format
- Free Report customization
- 4 months of analyst support

For more information https://www.reportocean.com/industry-verticals/sample-request?report_id=IC1655